Publication number: 20260069728
Abstract: A multi-targeting compound, a pharmaceutical composition comprising or consisting of same, a kit comprising or consisting of the compound or pharmaceutical composition, and the use of the compound or pharmaceutical composition in the diagnosis or treatment of diseases characterized by abnormal expression of FAP, CXCR4, GRPR, and/or ?v?3.
Type:
Application
Filed:
November 17, 2025
Publication date:
March 12, 2026
Applicants:
Chengdu Shetai Medical Technology Co., Ltd., Grand Pharma (China) Co., Ltd.
Inventors:
Weikun Tang, Shuheng Liang, Yaxin Shi, Feng Gao, Wentao Huang, Na Wu, Yiran Zhang, Xiaoyan Wu, Xixi Hu, Shimin Zhang, Shuqun Wang, Si Wen, Xiaoke Huang, Hongyu Yao, Jianxia Chen, Miao Yuan, Lina Ye, Dan Zhou, Ju Yang, Miao Wu, Qiao Wang